NYSEAMERICAN:NAVB - Navidea Biopharmaceuticals Price Target & Analyst Ratings

$0.51
-0.02 (-3.77 %)
(As of 08/16/2019 04:00 PM ET)
Today's Range
$0.50
Now: $0.51
$0.53
50-Day Range N/A
52-Week Range
$0.49
Now: $0.51
$7.40
Volume20,200 shs
Average Volume186,747 shs
Market Capitalization$5.13 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Navidea Biopharmaceuticals in the last 12 months. Their average twelve-month price target is $2.00, suggesting that the stock has a possible upside of 292.16%. The high price target for NAVB is $2.00 and the low price target for NAVB is $2.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyN/AN/A
Consensus Rating Score: 3.003.00N/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.00$2.00N/AN/A
Price Target Upside: 292.16% upside177.78% upsideN/AN/A

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Consensus Price Target History

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
8/9/2019Maxim GroupSet Price TargetBuy$2.00View Rating Details
(Data available from 8/17/2017 forward)
This page was last updated on 8/17/2019 by MarketBeat.com Staff

Featured Article: What are municipal bonds?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel